P. Abola and G. Jabishvili, “Incidence of Adverse and Safety Events in Individuals with Parkinson’s Disease Treated with Catechol-O-Methyltransferase Inhibitor Opicapone as an Add-On to Levodopa Treatment: A Systematic Review and Meta-Analysis”, Prospect. Pharm. Sci., no. 2025 (Early Access), Aug. 2025.